article thumbnail

Lupin acquires nine brands of Medical Nutritional Institute in South Africa

Express Pharma

This acquisition broadens our product range by concentrating on metabolic diseases such as cardiovascular disease, diabetes, and neuroscience, thereby enhancing patient health and well-being.” Mariaan du Plessis, CEO of MNI , shared her excitement about joining Pharma Dynamics. “We

article thumbnail

A history of Johnson & Johnson

pharmaphorum

During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. Weldon became the Chairman and CEO of J&J in 2002. Acquisitions post-Janssen. Between 1976 and 1989, James E. Burke was chairman and CEO of J&J. billion the following February.

Vaccines 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PharmaShots Weekly Snapshots (March 27 - 31, 2023)

PharmaShots

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

article thumbnail

Minority Health: The Importance of Patient Navigation and Access to Timely Care

Putting Patients First Blog

Washington (DC): National Academies Press (US); 2002. Similar patient experiences are supported by the 2003 Institute of Medicine’s (IOM) findings in Unequal Treatment that documented disparities in clinical interventions. 2 Unfortunately, health outcome indicators are still demonstrating inequities. [link]. DOI: [link].

article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Company: AstraZeneca First Approval Date: Jul 31, 2009 Generic Name: Saxagliptin Patent Expiration: Jan 2023 2022 Sales: $257M Indication: Type 2 Diabetes Mellitus Onglyza is a member of the dipeptidyl peptidase-4 inhibitor class of oral hypoglycemics used combined with diet and exercise for managing type 2 diabetes.

article thumbnail

A history of Pfizer

pharmaphorum

Others rapidly followed, including Glucotrol, aimed at diabetics, and Procardia, an anti-hypertensive. Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. The era of mega-mergers.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. Diabetic Neuropathy Diabetic neuropathy, a common complication of long-term high blood sugar and insulin resistance, can cause constipation. Curr Opin Endocrinol Diabetes Obes.